4[6]Dybul M,Fauol AS,Bartlett JG,et al. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep,2002,1(7):1～55
5[8]Massimo Andreoni. Cellular proviral HIV-DNA decline and viral isolation in naive subjects with＜5000 copies/ml of HIV-RNA and ＞ 500 × 106/l CD4 cells treated with highly aohve antiretroviral therapy. AIDS, 2000,14 (1): 23～29
6[9]Kaplan JE, Masur H, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infeoted. persons-2002. Recommendations of the U. S. PublicHealth Service and the Infectious Diseases Society ofAmerica. MMWR Recomm Rep, 2002,51 (RR-8): 1 ～ 52
7[10]Mofenson LM, Relatce Articles, Links. U. S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep, 2002,51 (18): 1 ～38
8[11]Bernardino Roca et al. A randomized,comparative study of iamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients,AIDS, 2000,14 (3) :0157～0161
10[13]Pythia T, Nieuwkerk Quality of life in asymptomatic and. symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. MMWR Recomm Rep, 2002:51
二级参考文献22
1李建华,朱华,万文鹏,石青,刘德全,Keith Emrich Christian J.Kroll.云南瑞丽物质滥用调查与社区干预[J].中国心理卫生杂志,1993,7(6):257-259. 被引量：80
7WHO/UNAIDS: Second Generation of HIV/AIDS surveillance.2000, 8 - 12.
8Family Health International: Behavioral Surveillance Surveys: Guidelines for Repeated Behavioral Surveil Lance Surveys in Population at Risk of HIV. 2000, 1 - 5.
